Toboroz
A Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)
NCT07876557· 2. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Wenhui Wang, Ph.D.
Toboroz
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07795346· 3. fázis· Antengene Biologics Limited· Forrás
Contact: Yanfang Gao
Még nem toboroz
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
NCT07466251· 4. fázis· Peking Union Medical College Hospital· Forrás
Contact: Weihai Xu, MD
Toboroz
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516· 2. fázis· Peking University People's Hospital· Forrás
Contact: Ming Li
Még nem toboroz
Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
NCT07797231· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Jianhong Chen, Master
Toboroz
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
NCT07714980· The Affiliated Hospital of Qingdao University· Forrás
Contact: Jianjun Qu
Toboroz
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
NCT07406035· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Jingjing Ma, Master
Toboroz
A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
NCT07496177· 2. fázis· Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences· Forrás
Contact: Xingpeng Shi
Toboroz
A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
NCT07509892· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Jingjing Ma, Master
Toboroz
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
NCT07379190· 3. fázis· Weifang Medical University· Forrás
Contact: Weili Li, MD
Toboroz
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
NCT07692165· 1/2. fázis· Innatus Therapeutics (Shanghai) Co., Ltd.· Forrás
Contact: Huang
Toboroz
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
NCT07477587· 1. fázis· Shanghai Henlius Biotech· Forrás
Contact: Yinping Zhong
Még nem toboroz
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599· 3. fázis· Beijing Tiantan Hospital· Forrás
Contact: Li Zhou
Toboroz
Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke
NCT07423975· 2. fázis· Beijing Tiantan Hospital· Forrás
Contact: Li Zhou
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455· Harbin Medical University· Forrás
Toboroz
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT07347600· Hoffmann-La Roche· Forrás
Toboroz
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
NCT07284134· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Guohua Yu, Doctor
Toboroz
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
NCT07185997· 3. fázis· ArriVent BioPharma, Inc.· Forrás
Contact: Clinical Trials
Fut, nem toboroz
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
NCT07162883· 3. fázis· Qilu Pharmaceutical Co., Ltd.· Forrás
Toboroz
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
NCT07168161· 3. fázis· Staidson (Beijing) Biopharmaceuticals Co., Ltd· Forrás
Contact: Jingjing Ma
Fut, nem toboroz
A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
NCT07245407· AstraZeneca· Forrás
Toboroz
TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
NCT07187687· Xuanwu Hospital, Beijing· Forrás
Contact: Yuting Wang
Toboroz
Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy
NCT07581210· 2. fázis· Shanghai QuietD Biotechnology Co., Ltd.· Forrás
Contact: Li Zhou
Toboroz
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
NCT07204275· 2/3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Toboroz
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT07047365· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Wenhui Wang, Master
Toboroz
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634· 3. fázis· Celcuity Inc· Forrás
Contact: Nadene Zack, MS
Még nem toboroz
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
NCT07007286· Peking University First Hospital· Forrás
Contact: Jing Feng
Toboroz
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06860971· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Wenhui Wang, Master
Toboroz
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
NCT07673029· 3. fázis· GeneQuantum Healthcare (Suzhou) Co., Ltd.· Forrás
Contact: Wenhui Wang
Meghívásos bevonás
INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer
NCT06747832· Korai 1. fázis· Guangzhou Ruixin Biotechnological Co., LTD· Forrás
Fut, nem toboroz
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
NCT06680921· 3. fázis· Jiangsu Simcere Pharmaceutical Co., Ltd.· Forrás
Toboroz
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971· 3. fázis· Capital Medical University· Forrás
Contact: Weili Li
Fut, nem toboroz
A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06711900· 3. fázis· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.· Forrás
Toboroz
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779· 3. fázis· Pfizer· Forrás
Toboroz
TEAS for Gastrectomy Recovery
NCT07898293· The Affiliated Hospital of Qingdao University· Forrás
Contact: Jianjun Qu, MD
Toboroz
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
NCT06662071· Qilu Hospital of Shandong University· Forrás
Contact: Yunjiang Zang
Toboroz
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules
NCT06423235· 4. fázis· Xintian Pharmaceutical· Forrás
Contact: Haixia Liu (sub-investigator)
Még nem toboroz
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
NCT06475599· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Guohua Yu, Bachelor
Fut, nem toboroz
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
NCT06419621· 3. fázis· Biotheus Inc.· Forrás
Még nem toboroz
Henagliflozin's Impact on Prediabetes Remission
NCT06448130· 4. fázis· Shandong Provincial Hospital· Forrás
Contact: Xiude Fan, MD&PhD
Fut, nem toboroz
Evolve China PMCF Study
NCT06368622· Stryker Neurovascular· Forrás
Toboroz
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
NCT06300177· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Wei Tan, Master
Toboroz
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
NCT06758557· 1/2. fázis· Huabo Biopharm Co., Ltd.· Forrás
Contact: PhD.
Toboroz
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
NCT06210776· Daiichi Sankyo· Forrás
Contact: Principal Investigator
Toboroz
A Study of YL202 in Selected Patients With Advanced Solid Tumors
NCT06107686· 2. fázis· MediLink Therapeutics (Suzhou) Co., Ltd.· Forrás
Contact: Coordinator Clinical operation director
Toboroz
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
NCT05913089· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Wei Tan, Doctor
Toboroz
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
NCT05590871· Shanghai Hongdian Medical CO., LTD· Forrás
Contact: Yuehui Yin, MD
Toboroz
OH2 Injection in Melanoma
NCT05868707· 3. fázis· Binhui Biopharmaceutical Co., Ltd.· Forrás
Contact: Wentao Xu
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
NCT05346224· 3. fázis· Shanghai Henlius Biotech· Forrás
Showing 50 of 57.